Last 7 days
Bookmark and Share    
See detailSignes dans les textes, texte sur les signes. Actes du Colloque international. Liège, 6-7 septembre 2013.
Macedo, Gabriel ULg; Scappaticcio, Maria Chiara

Book published by Presses Universitaires de Liège (in press)

Proceedings of the international conference held at the University of Liège in 2013. Contributions on the subject of ponctuation, accentuation, critical and lectional signs in Greek and Latin texts.

Detailed reference viewed: 47 (2 ULg)
Full Text
See detailQuelques observations sur la tenture de l’Histoire d’Hercule des Musées royaux d’Art et d’Histoire de Bruxelles
Laruelle, Anne-Sophie ULg

in Actes du neuvième congrès de l'Association des Cercles francophones d'Histoire et d'Archéologie de Belgique (in press)

Depuis 1953, les Musées royaux d’Art et d’Histoire possèdent quatre tapisseries, illustrant autrefois une Histoire d’Hercule, tissées durant la seconde moitié du XVIe siècle dans l'atelier bruxellois de ... [more ▼]

Depuis 1953, les Musées royaux d’Art et d’Histoire possèdent quatre tapisseries, illustrant autrefois une Histoire d’Hercule, tissées durant la seconde moitié du XVIe siècle dans l'atelier bruxellois de Frans Schavaert. La découverte de quatre autres pièces, dispersées dans diverses collections privées, a permis à quelques spécialistes de reconsidérer la tenture dans son ensemble. L’objectif de cette communication est de réexaminer cette suite, encore trop souvent méconnue des chercheurs, qui constitue un bel exemple, toujours conservé en Belgique, du style Renaissance dans l’art de la tapisserie bruxelloise. Cette intervention consiste à revoir les aspects iconographique et stylistique de la tenture, à retracer la date du tissage, particulièrement à l’aide des bordures, et à fournir de nouvelles données sur l’œuvre du licier [less ▲]

Detailed reference viewed: 51 (7 ULg)
Peer Reviewed
See detailTextes sur les signes: les sources latines
Macedo, Gabriel ULg

in Macedo, Gabriel; Scappaticcio, Maria Chiara (Eds.) Signes dans les textes, textes sur les signes. Actes du colloque international. Liège, 6-7 septembre 2013. (in press)

Detailed reference viewed: 33 (1 ULg)
Full Text
Peer Reviewed
See detailFred Dretske, Seeing and Knowing (chapitres 2.1 et 2.2)
Zincq, Aurélien ULg

in Gauvry, Charlotte; Brisart, Robert (Eds.) Perception et concept. Le conceptualisme en question (in press)

Detailed reference viewed: 20 (2 ULg)
Full Text
Peer Reviewed
See detailLa fondation d’une théorie de l’agentivité chez Heidegger à l’époque de Sein und Zeit
Zincq, Aurélien ULg

in Boccaccini, Federico; Cormann, Grégory (Eds.) Le soi agent: Approches phénoménologiques (in press)

Detailed reference viewed: 15 (0 ULg)
Full Text
Peer Reviewed
See detailFocus sur les lymphocytes T dans la maladie du greffon contre l'hôte après allogreffe de cellules soucges hématopoïétiques: implications pour de nouvelles stratégies de prévention
Vrancken, L; Delens, Loïc ULg; BEGUIN, Yves ULg et al

in Oncol. Hematol. (in press)

Malgré les stratégies de prévention actuelles, la maladie du greffon contre l’hôte (greffe-versus-hôte, GVH) aiguë (GVHa) reste une complication sévère et fréquente de l’allogreffe de cellules souches ... [more ▼]

Malgré les stratégies de prévention actuelles, la maladie du greffon contre l’hôte (greffe-versus-hôte, GVH) aiguë (GVHa) reste une complication sévère et fréquente de l’allogreffe de cellules souches hématopoïétiques. Bien que la physiopathologie de celle-ci ne reste que partiellement élucidée à ce jour, il est classiquement admis que les lymphocytes T (LT) jouent un rôle important dans son processus biologique. Les progrès récents de l’immunologie des LT dans la GVHa ont permis de diversifier les pistes visant à prévenir la survenue de cette complication post-greffe. Plusieurs approches sont en cours d’exploration dans des essais cliniques avec des résultats encourageant tels que la manipulation ex vivo des LT avant leur transfert chez le patient afin de leur faire exprimer des gènes suicide, l’élimination in vivo des LT proliférant directement après la greffe, l’inhibition de l’activation des LT en interférant avec les voies de signalisation en aval du TCR ou celles induites par les cytokines, l’induction de l’anergie des LT en bloquant les signaux de costimulation, le blocage de l’adressage des LT vers les organes lymphoïdes secondaires et les tissus cibles, la promotion de l’immunotolérance par la perfusion de lymphocytes T régulateurs ou par l’utilisation d’agents favorisant leur différenciation et leurs fonctions in vivo et la modulation de l’expression génique des cellules immunitaires par des modulateurs épigénétiques. Outre la prévention de la GVHa, le défi des nouvelles stratégies consiste également à ne pas compromettre l’effet bénéfique de la greffe contre la tumeur ni la reconstitution des défenses anti-infectieuses. [less ▲]

Detailed reference viewed: 23 (7 ULg)
Full Text
Peer Reviewed
See detailReduced intensity and non-myeloablative allogenic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin's lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy
Gauthier, J; Castagna, L; Garnier, F et al

in Bone Marrow Transplantation (in press)

Allogeneic stem cell transplantation (allo-SCT) following a non-myeloablative (NMA) or reduced-intensity conditioning (RIC) is considered a valid approach to treat patients with refractory/relapsed ... [more ▼]

Allogeneic stem cell transplantation (allo-SCT) following a non-myeloablative (NMA) or reduced-intensity conditioning (RIC) is considered a valid approach to treat patients with refractory/relapsed Hodgkin lymphoma (HL). When an HLA-matched donor is lacking a graft from a familial haploidentical (HAPLO) donor, a mismatched unrelated donor (MMUD) or cord blood (CB) might be considered. In this retrospective study, we compared the outcome of patients with HL undergoing a RIC or NMA allo-SCT from HAPLO, MMUD or CB. Ninety-eight patients were included. Median follow-up was 31 months for the whole cohort. All patients in the HAPLO group (N = 34) received a T-cell replete allo-SCT after a NMA (FLU-CY-TBI, N = 31, 91%) or a RIC (N = 3, 9%) followed by post-transplant cyclophosphamide. After adjustment for significant covariates, MMUD and CB were associated with significantly lower GvHD-free relapse-free survival (GRFS; hazard ratio (HR) = 2.02, P = 0.03 and HR = 2.43, P = 0.009, respectively) compared with HAPLO donors. In conclusion, higher GRFS was observed in Hodgkin lymphoma patients receiving a RIC or NMA allo-SCT with posttransplant cyclophosphamide from HAPLO donors. Our findings suggest they should be favoured over MMUD and CB in this setting. [less ▲]

Detailed reference viewed: 28 (2 ULg)
Full Text
Peer Reviewed
See detailOutcome after failure of allogeneic hematopoietic stem cell transplantation in children with acute leukemia: a study by the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
Rorhlich; Roux, C; Tifratene, K et al

in Bone Marrow Transplantation (in press)

Allogeneic hematopoietic stem cell transplantation (SCT) contributes to improved outcome in childhood acute leukemia (AL). However, therapeutic options are poorly defined in case of post-transplantation ... [more ▼]

Allogeneic hematopoietic stem cell transplantation (SCT) contributes to improved outcome in childhood acute leukemia (AL). However, therapeutic options are poorly defined in case of post-transplantation relapse. We aimed to compare treatment strategies in 334 consecutive children with acute leukemia relapse or progression after SCT in a recent ten-year period. Data could be analyzed in 288 patients (157 ALL, 123 AML and 8 biphenotypic AL) with a median age of 8.16 years at transplantation. The median delay from first SCT to relapse or progression was 182 days. The treatment consisted in chemotherapy alone (n=108), chemotherapy followed by second SCT (n=70), supportive/palliative care (n=67), combination of chemotherapy and DLI (n=30), or isolated reinfusion of donor lymphocytes (DLI) (n=13). The median OS duration after relapse was 164 days and differed according to therapy: DLI after chemotherapy = 385 d, second allograft = 391d, chemotherapy = 174d, DLI alone = 140d, palliative care = 43d. A second SCT or a combination of chemotherapy and donor lymphocytes infusion yielded similar outcome (HR=0.85, p=0.53) unlike chemotherapy alone (HR 1.43 p=0.04), palliative care (HR=4.24, p<0.0001) or isolated DLI (HR=1,94, p<0.04). Despite limitations in this retrospective setting, strategies including immunointervention appear superior to other approaches, mostly in AML. [less ▲]

Detailed reference viewed: 22 (1 ULg)
Full Text
Peer Reviewed
See detailThe clinical relevance of imatinib plasma trough concentrations in chronic myeloid leukemia. A Belgian study
Van Obbergh, F; Knoops, L; Devos, T et al

in Clinical Biochemistry (in press)

This retrospectivemulticenter study in patientswith chronic myeloid leukemia in chronic phasewas undertaken to confirm the clinical relevance of imatinib plasma concentrations monitoring in daily practice ... [more ▼]

This retrospectivemulticenter study in patientswith chronic myeloid leukemia in chronic phasewas undertaken to confirm the clinical relevance of imatinib plasma concentrations monitoring in daily practice. Forty-one patients, with 47 imatinib plasma measurements, were analyzed during treatment with imatinib given at a fixed 400mg daily dose. A significant inverse relationship of imatinib concentration with the patients' weight was observed (Pearson's test: p=0.02,R2=0.1). More interestingly, patientswith poor response (switched to another tyrosine kinase inhibitor because of imatinib failure, or because of disease progression after an initial response) displayed a significantly lower mean imatinib concentration as compared to patients maintained on imatinib (822 ng/mL vs 1099 ng/mL; Student's t-test, p=0.04). Failure or disease progression occurred more often in patients in the lowest quartile of imatinib concentrations compared to patients in the highest quartile (p = 0.02, logrank test). No correlation could be established with other biological or clinical parameter, including complete cytogenic response and majormolecular response. In conclusion: in patients treatedwith imatinib at a fixed daily dose of 400 mg, imatinib plasma concentrations decreased with increasing body weight and were lower in patients switched to another tyrosine kinase inhibitor due to imatinib failure. Systematic determination of imatinib plasma trough levels should be encouraged in such patients. [less ▲]

Detailed reference viewed: 16 (0 ULg)
Full Text
Peer Reviewed
See detailBattista Guarino, 'Sermone del cane e del cavallo'. Un texte inconnu à la cour des Este
Valenti, Gianluca ULg; Van den Abeele, Baudouin

in Actes du Colloque international Chevaux, chiens, faucons. L’art vétérinaire antique et médiéval à travers les sources écrites, archéologiques et iconographiques (in press)

Detailed reference viewed: 13 (5 ULg)
Full Text
Peer Reviewed
See detailChondrocyte secretome: a source of novel insights and exploratory biomarkers of osteoarthritis
Sanchez, Christelle ULg; Bay-Jensen, Anne-Christine; Pap, Thomas et al

in Osteoarthritis and Cartilage (in press)

Detailed reference viewed: 39 (4 ULg)
Full Text
Peer Reviewed
See detailA method for independent component graph analysis of resting-state fMRI. Brain and Behavior 2017, in press
Ribeiro de Paula, Demetrius; Ziegler, Erik; Abeyasinghe, P et al

in Brain and Behavior (in press)

Detailed reference viewed: 49 (1 ULg)
Full Text
Peer Reviewed
See detailSostanza e forma nella tradizione del romanzo arturiano in prosa
Leonardi, Lino; Morato, Nicola ULg

E-print/Working paper (in press)

Detailed reference viewed: 20 (2 ULg)
Full Text
See detailA fresh look on the limit on ultralight axion-like particles from SN1987A
Payez, Alexandre ULg

in 10th Patras Workshop on Axions, WIMPs and WISPs (in press)

We revisit the limit on very light axion-like particles (ALPs) from the absence of gamma rays coincidental with the neutrino burst from SN1987A. We use updated supernova simulations, modern models for the ... [more ▼]

We revisit the limit on very light axion-like particles (ALPs) from the absence of gamma rays coincidental with the neutrino burst from SN1987A. We use updated supernova simulations, modern models for the magnetic field inside the Galaxy, and a Primakoff cross section which takes into account proton-degeneracy and mass-reduction effects. We finally give an updated exclusion plot for the electromagnetic coupling of sub-eV ALPs, comparing our new bound with other limits as well as with future ALP searches. [less ▲]

Detailed reference viewed: 17 (7 ULg)
See detailDisorders of consciousness: new advances in neuroimaging techniques
Soddu, Andrea ULg; Bruno, Marie-Aurélie ULg; VANHAUDENHUYSE, Audrey ULg et al

in Zanotti, Bruno (Ed.) Vegetative State (in press)

Detailed reference viewed: 99 (11 ULg)
See detailAux sources des liturgies indo-iraniennes
Swennen, Philippe ULg; Redard, Céline ULg; Ferrer-Losilla, Joan Josep ULg et al

Book published by Collection Religion (Presses universitaires de l’Université de Liège) (in press)

Detailed reference viewed: 15 (1 ULg)
Full Text
See detailFin de siècle/Jahrhundertwende: Eine Tendenzgeschichte
Küpper, Achim ULg

in Roland, Hubert (Ed.) Eine kleine deutsch-französische Literaturgeschichte vom 18. Jahrhundert bis zum Ersten Weltkrieg (in press)

Detailed reference viewed: 34 (4 ULg)
Full Text
Peer Reviewed
See detailAnode (electro)catalysts for direct borohydride and ammonia borane fuel cells
Olu, Pierre-Yves ULg; Zadick, Anicet; Job, Nathalie ULg et al

in Electrocatalysts for low temperature fuel cells. Fundamental and recent trends. (in press)

Detailed reference viewed: 17 (3 ULg)